<DOC>
	<DOC>NCT00400608</DOC>
	<brief_summary>Collect PK/PD data for this age group to compare ADVAIR DISKUS with ADVAIR HFA</brief_summary>
	<brief_title>A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS</brief_title>
	<detailed_description>A repeat-dose open label randomized incomplete block design in pediatric subjects with asthma, ages 4-11 years, to compare systemic exposure and pharmacodynamics of fluticasone propionate and salmeterol following ADVAIR HFA 45/21mcg(2 inhalations), ADVAIR HFA 45/21mcg(2 inhalations) with Aerochamber Plus Spacer and ADVAIR DISKUS 100/50 twice daily</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone Propionate, Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>Inclusion criteria: Subjects with mild asthma No significant medical conditions at screen Weigh at least 20 kg Exclusion criteria: No clinical abnormalities at screen visit Asthma control at least 3 months prior with antisteroidal medication only</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>pediatrics</keyword>
	<keyword>ADVAIR Inhaler</keyword>
	<keyword>Asthma</keyword>
	<keyword>ADVAIR DISKUS</keyword>
</DOC>